Publications 2009
Modulation of p38 MAPK activity in regulatory T cells after tolerance with anti-DNA Ig peptide in (NZB x NZW)F1 lupus mice.
Loureno EV, Procaccini C, Ferrera F, Iikuni N, Singh RP, Filaci G, Matarese G, Shi FD, Brahn E, Hahn BH, La Cava A.
J Immunol. 2009 Jun 15;182(12):7415-21. doi: 10.4049/jimmunol.0804214.
Leptin concentrations in the peritoneal fluid of women with ovarian endometriosis are different according to the presence of a 'deep' or 'superficial' ovarian disease.
Alviggi C, Clarizia R, Castaldo G, Matarese G, Colucci CC, Conforti S, Pagano T, Revelli A, De Placido G.
Gynecol Endocrinol. 2009 Sep;25(9):610-5. doi: 10.1080/09513590903015577.
Leptin as clinical target
Cai C, Shi FD, Matarese G, La Cava A.
Recent Pat Inflamm Allergy Drug Discov. 2009 Nov;3(3):160-6.
Leptin in non-autoimmune inflammation.
Cai C, Hahn BH, Matarese G, La Cava A.
Inflamm Allergy Drug Targets. 2009 Sep;8(4):285-91.
Leptin signaling: A key pathway in immune responses.
Procaccini C, Lourenco EV, Matarese G, La Cava A.
Curr Signal Transduct Ther. 2009 Jan 1;4(1):22-30.
The Yin and Yang of CD4(+) regulatory T cells in autoimmunity and cancer.
Galgani M, Di Giacomo A, Matarese G, La Cava A.
Curr Med Chem. 2009;16(35):4626-31.
